Molecular and cellular pathways of neurodegeneration in motor neurone disease
about
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosisCell-based therapies for amyotrophic lateral sclerosis/motor neuron diseaseMinocycline for amyotrophic lateral sclerosis or motor neuron diseaseIntake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosisOld Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative DisordersTRPM7 and its role in neurodegenerative diseasesFlavin-containing monooxygenase mRNA levels are up-regulated in als brain areas in SOD1-mutant miceClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosisMechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosisScreening for replication of genome-wide SNP associations in sporadic ALSALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.An in vitro screening cascade to identify neuroprotective antioxidants in ALSWeighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patientsFatty acids in energy metabolism of the central nervous systemNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Literature-based discovery of diabetes- and ROS-related targets.Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.Iron metabolism disturbance in a French cohort of ALS patientsEffects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trialA comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective functionBim links ER stress and apoptosis in cells expressing mutant SOD1 associated with amyotrophic lateral sclerosis.Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.Oxidative stress biomarkers in sporadic ALSTryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.Multidisciplinary Interventions in Motor Neuron Disease.An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG GammopathyInhibition of Cytohesins Protects against Genetic Models of Motor Neuron Disease.Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.Quantification of the synaptosomal proteome of the rat cerebellum during post-natal development.TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapiesTargeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort.Mitochondria at the synapse.
P2860
Q21266563-A88F810A-D886-48D1-AA95-A0EA7FEAD59DQ24187577-CB84E3F7-9532-47D8-B301-8441B5F8ABE4Q24243793-C25C38B8-F343-4ACC-A12A-87A8A83D66D5Q24678388-E6DE8251-D0EC-4A5A-A726-93D9692BC4DEQ26775096-D247C1ED-D3EC-443C-8DC5-7C405CD85A50Q26798376-72B2F529-093D-4E89-AEC2-43D42591AAC3Q28298572-A4A60C74-2F96-483B-A3D2-2779BE805B4AQ28392768-5BBE131F-3031-46D2-9105-589D1F0C1DFEQ28475721-ABA982D1-36C8-4845-8AC4-1F483509AA4DQ28481295-2565499D-CA2A-4433-9274-4167C1DF361DQ28943381-B5392197-D1B4-42A8-99BB-2D59F2122291Q30619235-724B168F-D493-48A0-AA63-540F7A4153D2Q33338981-45259914-D7AE-4FB2-A6EA-ADA12C306FF0Q33445432-F164680B-0255-48FC-A787-2C5F4A6E0217Q33497640-DFF11636-C1A5-4079-9882-3EFAF2D3AB7EQ33634475-DF2C8086-34E9-472A-8E9B-BD5A8B7EDFF3Q33726019-B022EDFD-9A0A-4FD5-A508-9F2D04680250Q33729719-FCA5AC81-E614-44F7-B928-3F3425E43BA2Q33749062-EA4F1BD1-7F2B-43B1-9997-5BFE911661E4Q33791649-133E2B87-C4C6-4C92-8704-A6E549B7F35DQ33914518-37BC3689-A4D9-4B6E-9168-BBCA97DAA1B7Q33932196-0021BE99-6058-4D8A-95D4-68E1DF706AB5Q34029114-CA07BCCA-86FC-4D41-B226-8968AAB05380Q34241864-9C08BB97-FF10-44A6-B0F8-ECF570ACAF8EQ34541013-963225AE-F333-40E5-87D6-883C5643E994Q34544295-EDB43520-0183-4CC1-90DC-E10F287C95CDQ34978980-1040CEF2-EAAD-4B60-BB1F-3904CB5DD5B2Q35094635-731A2E9A-86A3-4E8B-8377-406F7BD4F026Q35366778-2AC3F26D-068E-42FF-90FD-5D599FA0A983Q35623262-F07C8F25-E7B2-4A8D-93CB-8649AE4A3599Q35649440-29B1C058-9C71-49DB-9375-131BBF3147BFQ35749188-7E89276F-E2A4-4715-B893-4DF35DBC05DEQ35894389-9FF75DA0-3F85-4C4A-974F-55B98EC9FB18Q35946526-CD598268-1538-407E-B3CB-DD01999E4458Q36015320-982F0910-4258-41AF-990B-EB5CAE225844Q36087937-817710F5-FC9D-4993-B840-0CF47B1D1685Q36117639-F5F5D112-3D27-4461-9A09-5FB2410AE5BFQ36201764-62D9BB24-450D-4577-AC49-EDE93A52B02CQ36320018-5EFEDEFC-F076-4102-AB0F-378A824BAA45Q36535662-96F40052-C3AE-41C9-AE9F-06143B2A4B49
P2860
Molecular and cellular pathways of neurodegeneration in motor neurone disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@ast
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@en
type
label
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@ast
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@en
prefLabel
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@ast
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@en
P2860
P356
P1476
Molecular and cellular pathways of neurodegeneration in motor neurone disease
@en
P2093
P2860
P304
P356
10.1136/JNNP.2004.048652
P407
P577
2005-08-01T00:00:00Z